Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
16.22x4.42x0.32x4.68x11.36x12.58x-.--% 1.16TCr
47.85x7.49x2.32x11.29x40.7x41.59x0.02% 5.16TCr
17.52x4.2x0.23x6.29x13.84x15.11x1.71% 4.39TCr
-25.49x74.37x-5.52x51.3x-29.13x-27.5x-.--% 3.17TCr
-26.75x1.23x-1.14x4.55x-12.55x-9.9x-.--% 2.73TCr
32.95x3.02x0.88x6.48x17.97x22.47x-.--% 2.12TCr
16.44x3.16x-5.76x3.85x10.18x10.76x-.--% 1.9TCr
-181.53x21.7x-2.08x44.66x-180.96x-159.61x-.--% 1.3TCr
-319.37x10.94x6.23x25.12x1057.07x-320.31x-.--% 1.25TCr
-11.52x - -0.04x143.92x-22.44x-11.29x-.--% 1.18TCr
-44.85x19.17x0.88x10.9x-37.96x-40.86x-.--% 1.09TCr
-18.52x16.39x-0x17.33x-22.17x-18.38x-.--% 881.08Cr
53.42x8.26x0.76x16.02x48.28x50.94x0.18% 854.81Cr
-10.21x-14.19x-0.49x92.2x-12.48x-12.21x-.--% 792.89Cr
-17.84x7.69x-0.39x - -18.31x-17.69x-.--% 792.72Cr
-9.91x - -0.22x - -9.12x-8.68x-.--% 789.27Cr
-150.16x16.37x1.83x18.42x564.7x-146.67x-.--% 761.17Cr
-21858.82x45.29x220.21x114.15x-1705.68x-1153.96x - 705.91Cr
Average -1,249.48x 14.34x 12.11x 35.70x -15.93x -98.53x 0.11% 1.72TCr
Weighted average by Cap. -514.26x 15.05x 4.71x 25.63x 14.30x -43.35x 0.26%
Bio Therapeutic Drugs